Differential teratogenic response of TNFα+/+ and TNFα-/- mice to cyclophosphamide: The possible role of NF-κB

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 6, 2006, Pages 437-444

  Torchinsky, Arkady ^a   Gongadze, Maka ^b   Savion, Shoshana ^a   Fein, Amos ^a   Toder, Vladimir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUTE OF PHYSICS   (Georgia)

Author keywords

Caspases; Cyclophosphamide; NF B; Teratogenesis; TNF

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLOPHOSPHAMIDE; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLORIMETRY; CONTROLLED STUDY; ECTRODACTYLY; EMBRYO; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXENCEPHALY; FETUS RESORPTION; FETUS WEIGHT; FINGER MALFORMATION; GASTROSCHISIS; HEMIMELIA; INTRAUTERINE GROWTH RETARDATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OMPHALOCELE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; SYNDACTYLY; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LIMB DEFORMITIES, CONGENITAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; TAIL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748284332     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20274     Document Type: Article

References (58)

1. Aleyasin H, Cregan SP, Iyirhiaro G, et al. 2004. Nuclear factor-kappaB modulates the p53 response in neurons exposed to DNA damage. J Neurosci 24:2963-2973.
2. Baud V, Karin M. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372-377.
3. Beg AA, Sha WC, Bronson RT, et al. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167-170.
4. Chen B, Cyr DG, Hales BF. 1994. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro. Teratology. 50:1-12.
5. Chernoff N, Rogers JM, Alles AJ, et al., 1989. Cell cycle alterations and cell death in cyclophosphamide teratogenesis. Teratog Carcinog Mutagen 9:199-209.
6. Degterev A, Boyce M, Yuan J. 2003. A decade of caspases. Oncogene. 22:8543-8567.
7. Doi TS, Marino MW, Takahashi T, et al. 1999. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96:2994-2999.
8. Gibson JF, Becker BA. 1968. The teratogenicity of cyclophosphamide in mice. Cancer Res 28:475-480.
9. Hayakawa M, Miyashita H, Sakamoto I, et al. 2003. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22:3356-3366.
10. Horton ND, Biswal SS, Corrigan LL, et al. 1999. Acrolein causes inhibitor κB-independent decreases in nuclear factor κB activation in human lung adenocarcinoma (A546) cells. J Biol Chem 274:9200-9206.
11. Huang C, Hales BF. 2002. Role of caspases in murine limb bud cell death induced by 4-hydroperoxycyclophosphamide, an activated analog of cyclophosphamide. Teratology 66:288-299.
12. Iseki A, Kambe F, Okumura K, et al. 2000a. Regulation of thyroid follicular cell function by intracellular redox-active copper. Endocrinology 141:4373-4382.
13. Iseki A, Kambe F, Okumura K, et al. 2000b. Pyrrolidine dithiocarbamate inhibits TNF-α-dependent activation of NF-kappaB by increasing intracellular copper level in human aortic smooth muscle cells. Biochem Biophys Res Commun 276:88-92.
14. Janssen-Heininger YM, Poynter ME, Baeuerle PA. 2000. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 28:1317-1327.
15. Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA. 2004. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104:1490-1497.
16. Karin M, Takahashi T, Kapahi P, et al. 2001. Oxidative stress and gene expression: the AP-1 and NF-κB connections. BioFactors 15:87-89.
17. Karin M, Yamamoto Y, Wang QM. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3:17-26.
18. Kennedy JC, Memet S, Wells PG. 2004. Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress. Mol Pharmacol 66:404-412.
19. Kim CH, Kim JH, Lee J, Ahn YS. 2003a. Zinc-induced NF-B inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol Appl Pharmacol 190:189-196.
20. Kim CH, Kim JH, Lee J, et al. 2003b. Thiol antioxidant reversal of pyrrolidine dithiocarbamate-induced reciprocal regulation of AP-1 and NF-kappaB. Biol Chem 384:143-150.
21. Knudsen TV. 1997. Cell death. In: Kavlock RJ, Daston GP, editors. Drug toxicity in embryonic development. Vol. I. Berlin: Springer-Verlag, pp. 211-244.
22. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. 2003. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22:8961-8982.
23. Li L, Hamilton RF Jr, Holian A. 1999. Effect of acrolein on human alveolar macrophage NF-κB activity. Am J Physiol 277:L550-L557.
24. Little SA, Mirkes PE. 2002. Teratogen-induced activation of caspase-9 and the mitochondrial apoptotic pathway in early postimplantation mouse embryos. Toxicol Appl Pharmacol 181:142-151.
25. Little SA, Kim WK, Mirkes PE. 2003. Teratogen-induced activation of caspase-6 and caspase-7 in early postimplantation mouse embryos. Cell Biol Toxicol 19:215-226.
26. Liu ZG. 2005. Molecular mechanism of TNF signaling and beyond. Cell Res 15:24-27.
27. Maddox JF, Domzalski AC, Roth RA, Ganey PE. 2004. 15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes. Toxicol Sci 77:290-298.
28. Malhotra V, Wong HR. 2002. Interactions between the heat shock response and the nuclear factor-kappa B signaling pathway. Crit Care Med 30(Suppl):S89-S95.
29. Martindale JL, Holbrook NJ. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15.
30. Mikheeva S, Barrier M, Little SA, et al. 2004. Alterations in gene expres-sion induced in day-9 mouse embryos exposed to hyperthermia (HS) or 4-hydroperoxycyclophosphamide (4CP): analysis using cDNA microarrays. Toxicol Sci 79:345-359.
31. Mirkes PE, Little SA. 1998. Teratogen-induced cell death in postimplantation mouse embryos: differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ 5:592-600.
32. Mirkes PE, Little SA. 2000. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol Appl Pharmacol 162:197-206.
33. Mirkes PE, Wilson KL, Cornel LM. 2000. Teratogen-induced activation of ERK, JNK, and p38 MAP kinases in early postimplantation murine embryos. Teratology 62:14-25.
34. Mirkes PE. 2002. 2001 Warkany lecture: to die or not to die, the role of apoptosis in normal and abnormal mammalian development. Teratology 65:228-239.
35. Moallem SA, Hales BF. 1998. The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development 125:3225-3234.
36. Moley KH. 2001. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 12:78-82.
37. Orlowski RZ, Baldwin AS Jr. 2002. NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8:385-389.
38. Phelan SA, Ito M, Loeken MR. 1997. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197.
39. Renard P, Ernest I, Houbion A, et al. 2001. Development of a sensitive multi-well colorimetric assay for active NF-kappaB. Nucleic Acids Res 29:E21.
40. Riedl SJ, Shi Y. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897-907.
41. Ryan KM, Ernst MK, Rice NR, Vousden KH. 2000. Role of NF-κB in p53-mediated programmed cell death. Nature 404:892-897.
42. Schert G, Steiner CW, Xu O, et al. 2003. TNFalpha mediates susceptibility to heat-induced apoptosis by protein phosphatase-mediated inhibition of the HSF1/hsp70 stress response. Cell Death Differ 10:1126-1136.
43. Senftleben U. 2003. NF-kappaB in critical diseases: a bad guy? Intensive Care Med 29:1873-1876.
44. Shakibaei M, Schulze-Tanzil G, Takada Y, Aggarwal BB. 2005. Redox regulation of apoptosis by members of the TNF superfamily. Antioxid Redox Signal 7:482-496.
45. Sokal RR, Rohlf FJ. 1995. Biometry, 3rd ed. New York: Freeman and Company; 244-249.
46. Terranova PF, Hunter VJ, Roby KF, Hunt JS. 1995. Tumor necrosis factor-α in the female reproductive tract. Proc Soc Exp Biol Med 209:325-342.
47. Toder V, Carp H, Fein A, Torchinsky A. 2002. The role of pro- and anti-apoptotic molecular interactions in embryonic maldevelopment. Am J Reprod Immunol 48:235-244.
48. Toder V, Fein A, Carp H, Torchinsky A. 2003. TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit? J Assist Reprod Genet 20:73-81.
49. Torchinsky A, Fein A, Toder V. 1995a. Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis. Teratog Carcinog Mutagen 15:179-190.
50. Torchinsky A, Fein A, Toder V. 1995b. Immunoteratology: I. MHC involvement in the embryo response to teratogens in mice. Am J Reprod Immunol 34:288-298.
51. Torchinsky A, Ivnitsky I, Savion S, et al. 1999. Cellular events and the pattern of p53 protein expression following cyclophosphamide-initiated cell death in various organs of developing embryo. Teratog Carcinog Mutagen 19:353-367.
52. Torchinsky A, Lishanski L, Wolstein O, et al. 2002. NF-kappaB DNA-binding activity in embryos responding to a teratogen, cyclophosphamide. BMC Dev Biol 2:2.
53. Torchinsky A, Shepshelovich J, Orenstein H, et al. 2003. TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol 49:159-168.
54. Torchinsky A, Toder V. 2004. To die or not to die: the function of the transcription factor NF-kappaB in embryos exposed to stress. Am J Reprod Immunol 51:138-143.
55. Torchinsky A, Gongadze M, Orenstein H, et al. 2004. TNF-alpha acts to prevent occurrence of malformed fetuses in diabetic mice. Diabetologia 47:132-139.
56. Torchinsky A, Fein A, Toder V. 2005. Teratogen-induced apoptotic cell death: does the apoptotic machinery act as a protector of embryos exposed to teratogens? Birth Defects Res C Embryo Today 75:353-361.
57. Torchinsky A, Gongadze M, Zaslavsky Z, et al. 2006. Maternal immunopotentiation affects caspase activation and NF-kappaB DNA-binding activity in embryos responding to an embryopathic stress. Am J Reprod Immunol 55:36-44.
58. Wu H-H, Momand J. 1998. Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J Biol Chem 273:18898-18905.